Matthew Kohler to Platinum
This is a "connection" page, showing publications Matthew Kohler has written about Platinum.
Connection Strength
0.047
-
A multicenter, randomized, phase 2 clinical trial to evaluate the efficacy and safety of combination docetaxel and carboplatin and sequential therapy with docetaxel then carboplatin in patients with recurrent platinum-sensitive ovarian cancer. Cancer. 2012 Jul 01; 118(13):3283-93.
Score: 0.024
-
Cost-effectiveness of combination versus sequential docetaxel and carboplatin for the treatment of platinum-sensitive, recurrent ovarian cancer. Cancer. 2012 Jan 15; 118(2):386-91.
Score: 0.023